Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma

OBJECTIVE: Hepatocellular carcinoma (HCC) is one of the most common and malignant tumors with an insidious onset, difficult early diagnosis, and limited therapy options, resulting in a poor prognosis. Cell division cycle associated 2 (CDCA2), also known as Repo-Man, plays an important role in regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Zhenjun, Zhang, Yu, Shao, Shuai, Liu, Qi, Li, Yuhan, Du, Xiaoxiao, Zhang, Kun, Zhang, Mengxia, Yuan, Haixia, Yuan, Qiang, Liu, Tong, Gao, Yingtang, Wang, Yijun, Hong, Wei, Han, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517522/
https://www.ncbi.nlm.nih.gov/pubmed/34660326
http://dx.doi.org/10.3389/fonc.2021.755814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517522/
https://www.ncbi.nlm.nih.gov/pubmed/34660326
http://dx.doi.org/10.3389/fonc.2021.755814

Ejemplares similares